Systematic-Review-Drug-Efficiency-Dissertation-Sample-Work-Tutors-India
Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b).
Idiopathic Pulmonary Fibrosis (IPF) as the name suggests is a progressive disorder with no known aetiology. It is characterised by the thickening of the alveoli due to scarring resulting in cough. It is known to primarily occur in older adults over 60 years of age. The findings of IPF have a known association of Usual Interstitial Pneumonia (UIP) (Raghu et al., 2011; Kawano-Dourado & Kairalla, 2013; Wells, 2013). It has been deemed that the prognosis is generally poor when UIP has been confirmed (King et al., 2001b). The median survival rate of IPF is 50%, typically around two years after diagnosis (Raghu et al., 2011; King et al., 2001b).
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Hillerdal, G., Nöu, E., Osterman, K. & Schmekel, B. (1984). Sarcoidosis: epidemiology and<br />
prognosis. A 15-year European study. The American review of respiratory disease. 130<br />
(1). pp. 29–32.<br />
Hiwatari, N., Shimura, S. & Takishima, T. (1993). Pulmonary emphysema followed by<br />
pulmonary fibrosis of undetermined cause. Respiration; international review of thoracic<br />
diseases. 60 (6). pp. 354–8.<br />
Holland, A. & Swigris, J. (2014). The Role of Pulmonary Rehabilitation and Supplemental<br />
Oxygen Therapy in the Treatment of Patients with Idiopathic Pulmonary Fibrosis. In: C.<br />
Meyer & D. Nathan (eds.). Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical<br />
Guide. Totowa, NJ: Humana Press, pp. 337–347.<br />
Holloway, I. & Wheeler, S. (2010). Qualitative research in nursing and healthcare. 3rd Ed.<br />
Oxford: Wiley-Blackwell.<br />
Homma, S., Azuma, A., Taniguchi, H., Ogura, T., Mochiduki, Y., Sugiyama, Y., Nakata, K.,<br />
Yoshimura, K., Takeuchi, M., Kudoh, S. & Japan NAC Clinical Study Group (2012).<br />
Efficacy of inhaled N-acetylcysteine monotherapy in patients with early stage idiopathic<br />
pulmonary fibrosis. Respirology (Carlton, Vic.). [Online]. 17 (3). pp. 467–77. Available<br />
from: http://www.ncbi.nlm.nih.gov/pubmed/22257422.<br />
Hoshino, M., Nakamura, Y., Sim, J., Shimojo, J. & Isogai, S. (1998). Bronchial subepithelial<br />
fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation.<br />
The Journal of allergy and clinical immunology. 102 (5). pp. 783–788.<br />
Howell, K. (2013). An Introduction to the Philosophy of Methodology. New York: SAGE<br />
Publications.<br />
Huang, H., Dai, H.P., Kang, J., Chen, B.Y., Sun, T.Y. & Xu, Z.J. (2015). Double-Blind<br />
Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis Patients.<br />
Medicine. [Online]. 94 (42). pp. e1600. Available from:<br />
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=0000579<br />
2-201510030-00014.<br />
Huang, J., Olivenstein, R., Taha, R., Hamid, Q. & Ludwig, M. (1999). Enhanced<br />
© 2017-2018 All Rights Reserved, No part of this document should be modified/used without prior consent<br />
<strong>Tutors</strong> <strong>India</strong> - Your trusted mentor since 2001<br />
www.tutorindia.com I UK # +44-1143520021, info@tutorsindia.com<br />
Page 130 of 172
Change language